-
1
-
-
82955187885
-
Antiplatelet agents for the treatment and prevention of atherothrombosis
-
Patrono C, Andreotti F, Arnesen H, et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J 2011;32:2922-32.
-
(2011)
Eur Heart J
, vol.32
, pp. 2922-2932
-
-
Patrono, C.1
Andreotti, F.2
Arnesen, H.3
-
2
-
-
0023923199
-
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
-
Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-19.
-
(1988)
N Engl J Med
, vol.318
, pp. 1714-1719
-
-
Schwartz, L.1
Bourassa, M.G.2
Lesperance, J.3
-
3
-
-
0028973172
-
Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)
-
Savage MP, Goldberg S, Bove AA, et al. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 1995;92:3194-200.
-
(1995)
Circulation
, vol.92
, pp. 3194-3200
-
-
Savage, M.P.1
Goldberg, S.2
Bove, A.A.3
-
4
-
-
65849268320
-
Antithrombotic Trialists (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
-
Baigent C, Blackwell L, Collins R, et al. Antithrombotic Trialists (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-60.
-
(2009)
Lancet
, vol.373
, pp. 1849-1860
-
-
Baigent, C.1
Blackwell, L.2
Collins, R.3
-
5
-
-
0030590746
-
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
-
CAPRIE Steering Committee
-
Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
-
(1996)
Lancet
, vol.348
, pp. 1329-1339
-
-
-
6
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.2
Hacke, W.3
-
7
-
-
9244251971
-
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
-
Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
-
(1996)
N Engl J Med
, vol.334
, pp. 1084-1089
-
-
Schomig, A.1
Neumann, F.J.2
Kastrati, A.3
-
8
-
-
7844220998
-
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study
-
Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 1998;98:1597-603.
-
(1998)
Circulation
, vol.98
, pp. 1597-1603
-
-
Bertrand, M.E.1
Legrand, V.2
Boland, J.3
-
9
-
-
0032481092
-
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators
-
Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-71.
-
(1998)
N Engl J Med
, vol.339
, pp. 1665-1671
-
-
Leon, M.B.1
Baim, D.S.2
Popma, J.J.3
-
10
-
-
0032542028
-
Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
-
Urban P, Macaya C, Rupprecht HJ, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998;98:2126-32.
-
(1998)
Circulation
, vol.98
, pp. 2126-2132
-
-
Urban, P.1
Macaya, C.2
Rupprecht, H.J.3
-
11
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann, J.T.3
-
12
-
-
34247869852
-
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
-
Bhatt DL, Flather MD, Hacke W, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007;49:1982-8.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1982-1988
-
-
Bhatt, D.L.1
Flather, M.D.2
Hacke, W.3
-
13
-
-
77956290748
-
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes
-
Investigators C-O, Mehta SR, Bassand JP, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 2010;363:930-42.
-
(2010)
N Engl J Med
, vol.363
, pp. 930-942
-
-
Mehta, S.R.1
Bassand, J.P.2
-
14
-
-
77958005516
-
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
-
Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010;376:1233-43.
-
(2010)
Lancet
, vol.376
, pp. 1233-1243
-
-
Mehta, S.R.1
Tanguay, J.F.2
Eikelboom, J.W.3
-
15
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
-
16
-
-
0035908781
-
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
-
Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
-
(2001)
Lancet
, vol.358
, pp. 527-533
-
-
Mehta, S.R.1
Yusuf, S.2
Peters, R.J.3
-
17
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
-
18
-
-
84867177857
-
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
-
Roe MT, Armstrong PW, Fox KA, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 2012;367:1297-309.
-
N Engl J Med
, vol.2012
, Issue.367
, pp. 1297-1309
-
-
Roe, M.T.1
Armstrong, P.W.2
Fox, K.A.3
-
19
-
-
84882909853
-
Elderly patients with acute coronary syndromes managed without revascularization: Insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel
-
Roe MT, Goodman SG, Ohman EM, et al. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel. Circulation 2013;128:823-33.
-
Circulation
, vol.2013
, Issue.128
, pp. 823-833
-
-
Roe, M.T.1
Goodman, S.G.2
Ohman, E.M.3
-
20
-
-
84882265903
-
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: A secondary, prespecified analysis of the TRILOGY ACS trial
-
Wiviott SD, White HD, Ohman EM, et al. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet 2013;382:605-13.
-
(2013)
Lancet
, vol.382
, pp. 605-613
-
-
Wiviott, S.D.1
White, H.D.2
Ohman, E.M.3
-
21
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
-
22
-
-
84856158305
-
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
-
Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
-
(2011)
Eur Heart J
, vol.32
, pp. 2999-3054
-
-
Hamm, C.W.1
Bassand, J.P.2
Agewall, S.3
-
23
-
-
82255188048
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: Substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
-
James SK, Roe MT, Cannon CP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ 2011;342:d3527.
-
(2011)
BMJ
, vol.342
, pp. d3527
-
-
James, S.K.1
Roe, M.T.2
Cannon, C.P.3
-
24
-
-
80052314039
-
Agreement between adjusted indirect comparison and simplified network meta-analyses on prasugrel and ticagrelor
-
Reply to Passaro et al. - Int J Cardiol 2011
-
Biondi-Zoccai G, D'Ascenzo F, Abbate A, et al. Agreement between adjusted indirect comparison and simplified network meta-analyses on prasugrel and ticagrelor (Reply to Passaro et al. - Int J Cardiol 2011). Int J Cardiol 2011;151:228-9.
-
(2011)
Int J Cardiol
, vol.151
, pp. 228-229
-
-
Biondi-Zoccai, G.1
D'Ascenzo, F.2
Abbate, A.3
-
25
-
-
84884820847
-
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis
-
Chatterjee S, Ghose A, Sharma A, et al. Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis. J Thromb Thrombolysis 2013;36:223-32.
-
(2013)
J Thromb Thrombolysis
, vol.36
, pp. 223-232
-
-
Chatterjee, S.1
Ghose, A.2
Sharma, A.3
-
26
-
-
40949088123
-
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events
-
Bowry AD, Brookhart MA, Choudhry NK. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol 2008;101:960-6.
-
(2008)
Am J Cardiol
, vol.101
, pp. 960-966
-
-
Bowry, A.D.1
Brookhart, M.A.2
Choudhry, N.K.3
-
27
-
-
84906656877
-
Ticagrelor vs. Clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: Results from the PLATO trial
-
Lindholm D, Varenhorst C, Cannon CP, et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J 2014.
-
(2014)
Eur Heart J
-
-
Lindholm, D.1
Varenhorst, C.2
Cannon, C.P.3
-
28
-
-
84898928011
-
Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome
-
Varenhorst C JK, Jernberg T, Sundström A, et al. Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome. Eur Heart J 2014:969-78.
-
Eur Heart J
, vol.2014
, pp. 969-978
-
-
Varenhorst, C.J.K.1
Jernberg, T.2
Sundström, A.3
-
29
-
-
77958128969
-
Guidelines on myocardial revascularization
-
Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55.
-
(2010)
Eur Heart J
, vol.31
, pp. 2501-2555
-
-
Wijns, W.1
Kolh, P.2
Danchin, N.3
-
30
-
-
84871258027
-
Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: A meta-analysis of randomized trials
-
Cassese S, Byrne RA, Tada T, et al. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. Eur Heart J 2012;33:3078-87.
-
(2012)
Eur Heart J
, vol.33
, pp. 3078-3087
-
-
Cassese, S.1
Byrne, R.A.2
Tada, T.3
|